Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Fieuws, S" or (type exact bookEditor and editor="Fieuws, S")

Add to list
- Journal Article
- A1
- open access
Late-onset Pompe disease (LOPD) in Belgium : clinical characteristics and outcome measures

P Vanherpe, S Fieuws, A D'Hondt, C Bleyenheuft, P Demaerel, Jan De Bleecker (UGent) , P Van den Bergh, J Baets, G Remiche, K Verhoeven, et al.

(2020) ORPHANET JOURNAL OF RARE DISEASES. 15(1).
Add to list
Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching

I Odnoletkova, G Goderis, F Nobels, S Fieuws, B Aertgeerts, Lieven Annemans (UGent) and D Ramaekers

(2016) DIABETIC MEDICINE. 33(6). p.777-785
Add to list
Outcome following laparoscopic and open total mesorectal excision for rectal cancer

F Penninckx, A Kartheuser, J Van de Stadt, Piet Pattyn (UGent) , B Mansvelt, C Bertrand, E Van Eycken, D Jegou and S Fieuws

(2013) BRITISH JOURNAL OF SURGERY. 100(10). p.1368-1375
Add to list
Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project

F Penninckx, K Beirens, S Fieuws, Wim Ceelen (UGent) , P Demetter, K Haustermans, J Van de Stadt and K Vindevoghel

(2012) COLORECTAL DISEASE. 14(7). p.E413-E421
Add to list
- Conference Paper
- C3
The physical activity level after the treatment for breast cancer: one-year follow-up

N Devoogdt, M Van Kampen, I Geraerts, T Coremans, S Fieuws, J Lefevre, Renaat Philippaerts (UGent) and MR Christiaens

(2010) EJC SUPPLEMENTS. 8(3). p.162-162
Add to list
- Conference Paper
- C3
Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition.

B Jacobs, R Van Oirbeek, B Biesmans, S Fieuws, W De Roock, J De Schutter, Y Humblet, Marc Peeters (UGent) , E Van Cutsem and S Tejpar

(2008) EJC SUPPLEMENTS. 6(12). p.31-31
Add to list
- Conference Paper
- C1
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treted with cetuximab: a fluorescent in situ hybridization study

N PERSONENI, S FIEUWS, H PIESSEVAUX, G DE HERTOGH, J DE SCHUTTER, B BIESMANS, W DE ROOCK, A CAPOEN, M DEBIEC-RYCHTER, J VAN LAETHEM, et al.

(2008) ClinCancer Res 2008. 14(18). p.5869-5869
Add to list
- Journal Article
- A1
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: A fluorescent in situ hybridization study

N PERSONENI, S FIEUWS, H PIESSEVAUX, G DE HERTOGH, J DE SCHUTTER, B BIESMANS, W DE ROOCK, A CAPOEN, M DEBIEC-RYCHTER, JL VAN LAETHEM, et al.

(2008) CLINICAL CANCER RESEARCH. 14(18). p.5869-5876

Academic Bibliography

Late-onset Pompe disease (LOPD) in Belgium : clinical characteristics and outcome measures

Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching

Outcome following laparoscopic and open total mesorectal excision for rectal cancer

Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project

The physical activity level after the treatment for breast cancer: one-year follow-up

Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition.

Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treted with cetuximab: a fluorescent in situ hybridization study

Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: A fluorescent in situ hybridization study

Contents

Support

Contact